Ovarian Cancer:
Ovarian Cancer, news on ovarian caner, early detection of ovarian cancer and treatment, symptoms and signs of ovarian cancer, clinical trials and ovarian cancer information.
-
Mar 11th, 2009
The early detection of ovarian cancer is possible when the treatment can still be provided for the disease, indicate the preliminary results from a large, continuing trial study . Currently only about one fourth of invasive ovarian cancer is found early.
-
Mar 9th, 2009
New legislation aimed at making February Ovarian Cancer Month is intended to bring greater awareness of ovarian cancer’s warning signs. Symptoms in ovarian cancer, such as bloating, are insidious and frequently ignored or attributed to weight gain or irritable bowel syndrome. For this reason, many women with ovarian cancer are not diagnosed until their conditions are advanced and much more likely to be resistant to treatment.
-
Feb 7th, 2009
Findings from a newly published study should reassure women and their doctors. The study found little association between the use of infertility drugs like Clomid and ovarian cancer.
-
Feb 6th, 2009
According to the results of a new study published in BMJ, there is no convincing association between ovarian cancer and fertility drugs.
-
Dec 29th, 2008
Obese and non-obese ovarian cancer patients have the same overall survival rates.
-
Dec 3rd, 2008
Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treatment of advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course.
-
Nov 19th, 2008
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences.
-
Nov 16th, 2008
A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die.
-
Nov 12th, 2008
A novel blood test that screens for microRNAs can reliably detect ovarian cancer, even among patients who test negative for the deadly disease with the widely used CA-125 blood test.
-
Oct 30th, 2008
Telik announced top-line results from an interrupted Phase 3 randomized study of Telcyta (canfosfamide HCL) in combination with pegylated liposomal doxorubicin (PLD) versus PLD alone in second-line therapy in platinum refractory, primary platinum resistant or secondary platinum resistant ovarian cancer.
